This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Endocrine gland, other/unspecified
CD2_BENIGN_ENDOCRINE_NOS_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Endocrine gland, other/unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Endocrine gland, other/unspecified
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 119 | 86 | 33 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.01 |
| Median age at first event (years) | 46.47 | 44.48 | 51.64 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 107
- Matched controls
- 1068
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D35.9
ICD-10 Finland
Benign neoplasm: Endocrine gland, unspecified
+∞
73.7
62
*
22680
ICD-8 Finland
Benign neoplasm of endocrine glands, Other specified endocrine glands
+∞
28.4
26
*
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
30.3
15.3
20
8
D35.7
ICD-10 Finland
Benign neoplasm: Other specified endocrine glands
+∞
13.8
13
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
53.1
12.2
14
*
JN4BD
NOMESCO Finland
Extensive body CT
14.2
10.3
17
14
101
Kela drug reimbursment
Anterior pituitary hypofunction
44.5
10.2
12
*
H02AB09
ATC
hydrocortisone; systemic
17.2
9.9
15
10
E23.00
ICD-10 Finland
Panhypopituitarism
60.6
9.8
11
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
60.6
9.8
11
*
D35.59
ICD-10 Finland
Other paragangliom
+∞
8.4
8
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
85.8
7.5
8
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
7.4
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.4
7
*
H02AB02
ATC
dexamethasone; systemic
32.4
7.3
9
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
74.1
6.5
7
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
6.3
6
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
6.3
38
158
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
19
55
3.92
6.02
1.8
2.0
0.2
0.2
g/l
0.21
19
48
8
6
14.16
5.15
3.4
1.0
4.3
5.9
nmol/l
—
8
6
26
114
2.64
4.15
3.6
2.0
0.8
0.8
mmol/l
1.50
26
107
9
15
6.39
3.89
1.1
1.7
—
—
—
0
0
8
16
5.28
3.11
3.6
2.4
—
—
—
0
0
7
13
5.64
2.91
1.3
1.1
—
—
—
0
0
68
521
1.71
2.15
11.8
5.6
3.9
4.1
e9/l
0.30
58
447
5
10
5.16
2.09
2.0
1.7
—
—
—
0
0
22
122
1.99
2.01
1.7
2.7
2.4
2.3
g/l
0.12
17
112
5
12
4.30
1.84
1.0
1.1
—
—
—
0
0
10
46
2.28
1.44
4.0
6.3
1.5
1.6
%
—
10
46
6
24
2.58
1.32
3.2
1.2
45.8
68.5
pmol/l
—
6
24
6
25
2.47
1.26
4.3
4.6
24.2
25.6
mmol/l
—
6
25
16
94
1.81
1.25
3.6
5.0
-0.0
1.3
mmol/l
0.92
11
75
51
402
1.47
1.22
3.5
3.3
—
—
—
0
0
58
469
1.46
1.22
8.3
4.8
1.2
1.2
mmol/l
0.05
52
406
49
388
1.45
1.13
3.9
3.7
27.9
32.9
ng/l
0.15
37
274
30
218
1.50
1.06
2.2
2.0
4.5
2.9
mg/l
0.69
25
183
28
203
1.50
1.00
1.5
1.6
0.6
1.1
mg/l
1.10
17
158
7
37
1.95
0.95
1.6
3.1
—
—
—
0
0
18
119
1.60
0.95
2.4
1.7
—
—
—
0
0
9
52
1.79
0.95
1.3
1.3
—
—
—
0
0
26
190
1.47
0.89
1.7
1.8
—
—
—
0
0
84
754
1.39
0.85
4.3
4.3
12.2
11.7
mm/h
0.10
76
689
37
292
1.39
0.84
4.0
2.0
2.4
2.4
mmol/l
0.18
31
246
85
766
1.38
0.82
5.1
4.1
15.2
14.6
pmol/l
1.29
85
700
15
99
1.59
0.80
1.7
2.1
27.7
5.7
umol/l
0.46
15
83
57
486
1.33
0.79
4.4
4.9
0.0
0.0
estimate
0.00
11
89
9
56
1.66
0.74
3.3
4.4
25.9
25.2
mmol/l
—
9
56
9
56
1.66
0.74
1.7
3.8
4.4
4.7
pmol/l
—
9
50
7
39
1.84
0.74
2.6
1.7
—
—
—
0
0
5
25
2.04
0.73
1.4
1.6
—
—
—
0
0
5
26
1.96
0.71
1.6
1.7
—
—
—
0
0
57
492
1.30
0.70
3.5
3.6
0.0
0.0
estimate
0.00
12
89
5
94
0.51
0.70
2.2
1.9
—
—
—
0
0
56
483
1.30
0.69
3.7
3.6
0.0
0.0
estimate
—
10
90
32
258
1.33
0.63
4.5
3.6
0.0
0.0
estimate
0.00
12
89
5
30
1.70
0.62
1.0
1.3
—
3.7
—
0
7
47
401
1.28
0.62
2.7
2.4
74.1
77.7
nmol/l
0.44
42
354
94
994
0.74
0.59
5.3
5.3
2.6
2.8
mmol/l
1.16
88
917
26
206
1.34
0.57
3.1
3.5
17.2
97.0
ng/l
0.78
21
158
15
108
1.44
0.56
11.3
7.7
—
—
—
0
0
44
377
1.27
0.55
3.8
3.6
—
—
—
0
0
20
154
1.36
0.53
4.7
3.0
0.6
3.4
e6/l
—
10
76
92
970
0.77
0.49
4.5
4.7
1.5
1.5
mmol/l
0.25
87
895
97
918
1.31
0.48
5.6
4.9
1.8
3.2
mu/l
0.53
89
836
0
17
0.00
0.41
0.0
1.1
—
2.4
—
0
10
35
302
1.23
0.40
2.6
3.0
1178.5
990.8
ng/l
0.20
30
251
37
324
1.21
0.37
5.6
2.9
—
—
—
0
0
6
43
1.42
0.35
1.3
1.8
—
—
—
0
0
95
909
1.22
0.33
16.2
10.9
82.0
78.1
ml/min/173m2
1.14
82
724
6
46
1.32
0.33
1.2
1.3
—
—
—
0
0
10
74
1.38
0.33
4.8
1.9
68.0
65.7
ml/min/173m2
—
5
28
7
51
1.40
0.32
5.4
3.5
4.7
5.2
kpa
—
7
46
19
157
1.25
0.32
4.7
2.8
0.4
1.2
e6/l
—
9
78
15
181
0.80
0.27
1.1
1.4
—
—
—
0
0
11
86
1.31
0.27
2.5
1.7
—
—
—
0
0
32
286
1.16
0.25
1.5
1.7
1.3
1.3
mmol/l
0.20
27
243
23
200
1.19
0.24
1.7
1.8
475.5
461.6
pmol/l
0.07
18
161
11
88
1.28
0.23
2.9
1.7
—
—
—
0
0
90
930
0.87
0.22
5.6
5.9
38.9
39.8
mmol/mol
0.55
85
868
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
7
58
1.22
0.18
1.0
1.1
—
—
—
0
0
17
193
0.86
0.17
1.2
1.3
4.1
14.2
u/ml
—
6
69
100
977
1.15
0.16
18.6
11.4
17.0
20.5
mg/l
0.69
82
735
14
161
0.85
0.16
4.9
3.4
17.0
25.9
%
—
9
69
91
934
0.89
0.16
4.1
4.2
1.3
1.3
mmol/l
0.20
85
853
10
83
1.22
0.16
2.6
3.0
—
—
—
0
0
14
159
0.86
0.14
1.5
1.5
—
—
—
0
0
95
965
0.92
0.08
5.0
4.6
5.7
6.0
mmol/l
2.13
86
885
6
71
0.84
0.08
4.7
3.0
1.2
1.2
mmol/l
—
6
59
9
100
0.89
0.06
3.0
1.8
1.5
1.5
%
—
9
89
104
1032
1.06
0.02
20.7
13.6
72.7
75.9
umol/l
0.83
104
1032
27
263
1.03
0.01
5.9
3.0
1.8
0.4
e6/l
0.40
20
188
20
194
1.04
0.00
1.2
1.3
14.6
43.2
iu/ml
—
6
64
57
568
1.01
0.00
3.0
2.9
—
—
—
0
0
43
425
1.02
0.00
2.3
1.9
103.0
97.7
pmol/l
0.35
30
202
25
251
0.99
0.00
3.0
2.2
23955.3
3383.0
umol/l
0.40
18
213
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
166.1
—
0
5
0
5
0.00
0.00
0.0
5.2
—
685.8
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.1
—
14.1
—
0
9
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_ENDOCRINE_NOS_EXALLC – Benign neoplasm: Endocrine gland, other/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).